medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2023, Number 06

<< Back Next >>

Ginecol Obstet Mex 2023; 91 (06)

Description of a population of pregnant women with Rh (D) incompatibility

Durango-Sánchez C, Martínez-Sánchez LM, Vásquez-Estrada V, Jaramillo-Jaramillo LI, Zapata-Cardona LM, Campo-Campo MN

Language: Spanish
References: 14
Page: 411-416
PDF size: 305.89 Kb.


ABSTRACT

Objective: To determine the maternal and fetal outcomes in pregnant women with Rh D incompatibility.
Materials and Methods: A Retrospective cohort study carried out in the Maternal and Child Unit of Medellín, Colombia, in pregnant patients attended between 2013 and 2018.
Results: 250 patients were included, in which the median age was 26 years. The O- blood type was the most prevalent in pregnant women with 55.2% and 49.2% of the patients had had between 2 and 3 previous pregnancies, in addition, 88% of the patients had not presented any sensitizing event during her pregnancy. 65.2% had a negative first Coombs result and the mean gestational age of the first Coombs was 28 weeks. 48% of patients received immunoglobulin G anti D at a median gestational age of 28 weeks.
Conclusion: The present study confirms the clinical and sociodemographic data, however it suggests that it may be necessary to strengthen the opportunity in the early recruitment of patients for follow-up with Coombs and for the indication of prophylaxis.


REFERENCES

  1. Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.Obstet Gynecol. 2017;130(2):e57-e70. doi: 10.1097/AOG.0000000000002232.

  2. Zapata-Cardona L, Martínez-Sánchez L, Jaramillo-JaramilloL. Incompatibilidad Rh e isoinmunización en la gestante.Revista Cubana de Obstetricia y Ginecología. 2020; 46 (1)Disponible en: https://revginecobstetricia.sld.cu/index.php/gin/article/view/600

  3. Gudlaugsson B, Hjartardottir H, Svansdottir G, GudmundsdottirG, Kjartansson S, et al. Rhesus D alloimmunization inpregnancy from 1996 to 2015 in Iceland: a nation-wide populationstudy prior to routine antenatal anti-D prophylaxis.Transfusion. 2020;60(1):175-183. doi: 10.1111/trf.15635.

  4. Fuenzalida J, Carvajal JA. Manejo de la embarazada conisoinmunización por anticuerpos irregulares. Rev ChilObstet Ginecol. 2014;79(4):315–22. DOI: 10.4067/S0717-75262014000400011.

  5. Lambertino JR, Villegas SM. Aloinmunización Rh en mujeresgestantes, una mirada al diagnóstico y a su aproximaciónterapéutica. Ginecol Obstet Mex. 2014;82:744-754.

  6. Management of Alloimmunization During Pregnancy.Practice Bulletin No. 192. American College of Obstetriciansand Gynecologist. 2018;131(3):e82-90. DOI: 1097/AOG.0000000000002525

  7. RCOG Green-top Guideline No. 65. Royal College ofObstetricians and Gynaecologists. 2014. Disponible en:https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg65.

  8. Society for Maternal-Fetal Medicine (SMFM) ClinicalGuideline #8: The fetus at risk for anemia-diagnosis andmanagement. Am J Obstet Gynecol. 2015;697-710. DOI:10.1016/j.ajog.2015.01.059.

  9. Brítez C, Samudio-D G. Costo ocasionado por la enfermedadhemolítica del recién nacido por incompatibilidad Rhvs costo de la profilaxis. Pediatr (Asunción). 2018; 34(1):15-23. Disponible en: https://www.revistaspp.org/index.php/pediatria/article/view/312

  10. Gudlaugsson B, Hjartardottir H, Svansdottir G, GudmundsdottirG, Kjartansson S, Jonsson T, et al. Rhesus D alloimmunizationin pregnancy from 1996 to 2015 in Iceland: anation-wide population study prior to routine antenatalanti-D prophylaxis. Transfusion. 2020;60(1):175-183.doi:10.1111/trf.15635

  11. Baptista-González HA, Rosenfeld-Mann F, Leiss-MárquezT. Prevención de la isoinmunización materna al RhD, congamma-globulina anti-D [Prevention of maternal RhDisoimmunization with anti-D gamma isoimmunization].Salud Publica Mex. 2001;43(1):52-58. doi:10.1590/s0036-36342001000100007

  12. Moise KJ Jr, Argoti PS. Management and prevention ofred cell alloimmunization in pregnancy: a systematicreview. Obstet Gynecol. 2012;120:1132. DOI: 10.1097/AOG.0b013e31826d7dc1.

  13. López-Carpintero N, Rodríguez-González R, González-González A, Díez-Sánchez J. Papel del Doppler en la arteriacerebral media en la atención de pacientes con isoinmunizaciónRhesus [Role of middle cerebral artery Dopplerin the management of Rhesus alloimmunization cases].Ginecol Obstet Mex. 2010;78(8):410-417.

  14. Dodd JM, Andersen C, Dickinson JE, Louise J, Deussen A,Grivell RM, et al. Fetal middle cerebral artery Dopplerto time intrauterine transfusion in red-cell alloimmunization:a randomized trial. Ultrasound Obstet Gynecol.2018;51(3):306-312. doi:10.1002/uog.18807




2020     |     www.medigraphic.com